Natera CEO sells 3,076 shares under trading plans
Natera, Inc. director, CEO and President Steven Leonard Chapman reported selling 3,076 shares of Common Stock on August 3, 2026.
Rhea-AI Filing Summary
Natera, Inc. director, CEO and President Steven Leonard Chapman reported selling 3,076 shares of Common Stock on August 3, 2026. One sale of 1,182 shares at $267.9893 was to satisfy tax withholding and remittance obligations on vesting RSUs under a written instruction intended to meet Rule 10b5-1(c) affirmative defense conditions. Additional tranches, ranging from 70 to 612 shares, were sold under a pre-arranged Rule 10b5-1 trading plan adopted December 11, 2023 and later amended, at per-share or weighted-average prices in ranges such as $263.29–$264.24, $266.58–$267.54 and $267.8350–$268.7700.
Positive
- None.
Negative
- None.
Insights
Analyzing...
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1 | 1,182 | $267.9893 | $317K |
| Sale | Common Stock F2 | 160 | $259.98 | $42K |
| Sale | Common Stock F2 | 70 | $261.025 | $18K |
| Sale | Common Stock F2, F3 | 676 | $263.8622 | $178K |
| Sale | Common Stock F2 | 80 | $265.27 | $21K |
| Sale | Common Stock F2, F4 | 296 | $267.0838 | $79K |
| Sale | Common Stock F2, F5 | 612 | $268.2187 | $164K |
Footnotes (5)
- F1. The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 31, 2025.
- F2. The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023, as amended on December 2, 2024, and as further amended on March 5, 2026.
- F3. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $263.29 to $264.24 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F4. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $266.58 to $267.54 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F5. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $267.8350 to $268.7700 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
weighted average price financial
RSUs financial
affirmative defense conditions regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider stock sales did Natera (NTRA) disclose for August 3, 2026?
Were the Natera (NTRA) insider sales made under a Rule 10b5-1 plan?
Does the Natera (NTRA) Form 4 show remaining holdings for the CEO after these sales?
AI-generated analysis. How Rhea-AI works. Not financial advice.